GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » Common Stock

GeneTether Therapeutics (XCNQ:GTTX) Common Stock : C$5.63 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics Common Stock?

GeneTether Therapeutics's quarterly common stock increased from Jun. 2023 (C$5.57 Mil) to Sep. 2023 (C$5.68 Mil) but then declined from Sep. 2023 (C$5.68 Mil) to Dec. 2023 (C$5.63 Mil).

GeneTether Therapeutics's annual common stock increased from Dec. 2021 (C$1.60 Mil) to Dec. 2022 (C$5.67 Mil) but then declined from Dec. 2022 (C$5.67 Mil) to Dec. 2023 (C$5.63 Mil).


GeneTether Therapeutics Common Stock Historical Data

The historical data trend for GeneTether Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics Common Stock Chart

GeneTether Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Common Stock
0.21 1.60 5.67 5.63

GeneTether Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.67 5.73 5.57 5.68 5.63

GeneTether Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


GeneTether Therapeutics (XCNQ:GTTX) Business Description

Traded in Other Exchanges
N/A
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3
GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines